2024-10-11 - Analysis Report
## Cigna Group (CI) Stock Analysis Report

**Company Overview:** Cigna is a global health services company that offers health insurance, pharmacy benefits, and other related products and services.

**Performance Analysis:**

**1. Relative Performance:**

* **Cumulative Return:**  CI has returned 153.69% compared to the S&P 500's (VOO) return of 134.82%. 
* **Outperformance:** CI has outperformed the S&P 500 by 18.87%.
* **Relative Outperformance:** This represents a 45.25% position within the historical range of outperformance (max: 92.73, min: -29.43).

**2. Recent Price Movement:**

* **Closing Price:** $346.72
* **5-Day Moving Average:** $342.64
* **20-Day Moving Average:** $350.88
* **60-Day Moving Average:** $346.94
* **Analysis:** The stock is trading slightly below its 20-day and 60-day moving averages, indicating potential for short-term downward pressure. However, the 5-day moving average is below the current price, suggesting a potential rebound.

**3. Technical Indicators:**

* **RSI:** 39.34 - This suggests the stock is currently oversold and may be ripe for a potential rebound. 
* **PPO:** -0.31 - A negative PPO indicates a bearish trend, but the value is close to zero, suggesting the trend may be weakening.
* **Delta_Previous_Relative_Divergence:** -15.01 - This indicates a recent short-term downward trend in relative outperformance.
* **Expected Return:** 21.3% - This suggests a potential for substantial upside return in the next 5 years, relative to the S&P 500. 

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-08-01 | 5.51 | 60.52 B$ |
| 2024-05-02 | -0.97 | 57.26 B$ |
| 2023-11-02 | 4.79 | 49.05 B$ |
| 2023-08-03 | 4.96 | 48.59 B$ |
| 2024-08-01 | 4.96 | 48.59 B$ |

* **Analysis:** The most recent earnings (2024-08-01) were a significant positive surprise, exceeding analyst expectations. This suggests strong underlying business performance. However, the previous quarter saw a loss, indicating potential volatility in earnings. 

**5. News and Recent Issues:**

* **Recent Market Outlook:**  While some analysts remain bullish on Cigna's future growth due to its strong market position and potential for continued revenue growth, others are more cautious, citing concerns about rising healthcare costs and potential regulatory headwinds.
* **Analyst Opinions:** Analyst sentiment on Cigna is generally positive, with many analysts rating the stock as "buy" or "outperform." 
* **Performance Highlights:**  Cigna has been consistently outperforming the broader market in recent years, driven by strong revenue growth and market share gains.
* **FINBOLD:** FINBOLD provides a summary of recent news and analyst ratings. 

**6. Overall Analysis:**

Cigna (CI) presents a compelling investment case, boasting strong financial performance and a track record of outperforming the market. The stock's recent price movement suggests potential for volatility, but its technical indicators and strong earnings signal a potential rebound. While there are concerns about rising healthcare costs and regulatory headwinds, Cigna's position as a dominant player in the health insurance market provides a strong foundation for future growth.

**7. Recommendation:**

Based on the current analysis, CI appears to be a worthwhile investment for investors seeking long-term growth potential.  

**Disclaimer:** This report is intended for informational purposes only and should not be construed as financial advice. 
